Prof. Marcello D'amelio
Full Professor of Human Physiology. Since 2015 he has been Head of the Molecular Neuroscience Research Unit and since 2010 he has been Director of the Molecular Neuroscience Laboratory. From 2019 to 2022 he was Research Coordinator of the Departmental Faculty of Science and Technology for Man and the Environment.
Biography
Marcello D'Amelio,
PhD in Neuroscience
M.Sc. in Clinical Experimentation
Curriculum Vitae
current position
• Full Professor of Human Physiology, Medical School University Campus-Biomedico, Rome, (I);
• Research Coordinator of the Department of Medicine and Surgery
• Group leader at the European Brain Research Center (CERC) – IRCCS Santa Lucia Foundation IRCCS, Rome (I);
• Member of Scientific Committee, Center of Molecular Nutrition for Sport (www.cmnsport.com);
Current Research Interests
Analysis of synaptic and neuronal degeneration in rodent models of Alzheimer's Disease and other neurological disorders; Apoptosis and Autophagy applied to neuroscience field.
Professional Society Membership
• Since 2003 Member of the Italian Society of Biochemistry and Molecular Biology
• Since 2004 Member of the Society of Neuroscience
• Since 2010 Member of the Italian Society of Pharmacology
Editorial activity
• Associate Editor of Translational Research in Dementia;
• Member of Editorial Board of Neuromolecular Medicine, Scientific Reports;
• Guest Editor of Current Pharmaceutical Design
• Referee of Journal of Alzheimer's disease, NeuroMolecular Medicine, Journal of Neuroscience Research, World Journal of Pharmacology, European Journal of Neurodegenerative diseases and Cell Death and Disease.
Grants
- Modulating synaptic neurotransmission to reactivate the immune reaction against brain tumors. MUR - PRIN 2020 – Role: Unit's PI
- Dopamine loss and neuroinflammation in Alzheimer's Disease: two sides of the same coin?” Alzheimer Association, USA - AARG-21-851219; Role: Coordinator
- New natural neuroprotective molecules to slow the progression of AD” within the CurAlz Project POR A0375-2020-36665; Role: Co-Pi
- Beyond Amyloid Hypothesis: a novel approach to fight Alzheimer's Disease, Fondazione Roma, Role: Coordinator
- Pharmacological and non-pharmacological recruitment of dopaminergic mesolimbic pathway in early AD; Farmindustria, Italy: Role: Coordinator
- Targeting dopamine neuronal loss in a model of Alzheimer's Disease – Alzheimer Association, USA - AARG-18-566270, Role: Coordinator
- Ventral Tegmental Area dopaminergic midbrain: new therapeutic target in early Alzheimer's Disease – Italian Ministry of Health RF-2028-1236552; Role: Coordinator
Patents
Autophagy enhancing compounds, peptides and peptidomimetic compounds for use in the treatment of neuronal diseases - PCT Patent 2012/076555.
PUBLICATIONS
Please check the following link:
https://orcid.org/0000-0001-6526-1832
